Chloramphenicol Sodium Succinate For Injection Bột vô khuẩn pha tiêm Vietnam - vietnami - BỘ Y TẾ (CỤC QUẢN LÝ DƯỢC)

chloramphenicol sodium succinate for injection bột vô khuẩn pha tiêm

brawn laboratories ltd - chloramphenicol sodium succinate - bột vô khuẩn pha tiêm - 1g chloramphenicol

MINIMS CHLORAMPHENICOL 0.5 % EYE DROPS, SOLUTION Írország - angol - HPRA (Health Products Regulatory Authority)

minims chloramphenicol 0.5 % eye drops, solution

bausch & lomb uk limited - chloramphenicol - eye drops solution - 0.5 per cent - chloramphenicol

CHLORAMPHENICOL GPPL chloramphenicol 5 mg/mL eyedrops bottle Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

chloramphenicol gppl chloramphenicol 5 mg/ml eyedrops bottle

arrotex pharmaceuticals pty ltd - chloramphenicol, quantity: 5 mg/ml - eye drops - excipient ingredients: phenylmercuric nitrate; borax; boric acid; water for injections - for the treatment of bacterial conjunctivitis. for use under medical supervision only in the treatment of other superficial ocular infections caused by chloramphenicol sensitive organisms.

CHLORAMPHENICOL AH chloramphenicol 5 mg/mL eyedrops bottle Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

chloramphenicol ah chloramphenicol 5 mg/ml eyedrops bottle

juno pharmaceuticals pty ltd - chloramphenicol, quantity: 5 mg/ml - eye drops - excipient ingredients: water for injections; boric acid; borax; phenylmercuric nitrate - for the treatment of bacterial conjunctivitis. for use under medical supervision only in the treatment of other superficial ocular infections caused by chloramphenicol sensitive organisms.

LEUKERAN- chlorambucil tablet, film coated Egyesült Államok - angol - NLM (National Library of Medicine)

leukeran- chlorambucil tablet, film coated

aspen global inc. - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) - chlorambucil 2 mg - leukeran (chlorambucil) is indicated in the treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and hodgkin’s disease. it is not curative in any of these disorders but may produce clinically useful palliation. chlorambucil should not be used in patients whose disease has demonstrated a prior resistance to the agent. patients who have demonstrated hypersensitivity to chlorambucil should not be given the drug. there may be cross-hypersensitivity (skin rash) between chlorambucil and other alkylating agents.